Bio-Rad Laboratories IncBIO

BIO current price
$277.16-19.37%

Capital at risk.

1W
-17.12%
1M
-18.94%
3M
-11.49%
6M
-15.07%
1Y
-19.37%
MAX
+133.30%
About Bio-Rad Laboratories Inc
Ticker
info
BIO
Trading on
info
NYSE
ISIN
info
US0905722072
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Norman D. Schwartz
Headquarters
info
1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Employees
info
7,700
Website
info
bio-rad.com
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Metrics
BasicAdvanced
Market cap
info
$8.73B
P/E ratio
info
-
EPS
info
-$28.08
Dividend Yield
info
0.00%
Beta
info
0.94
Forward P/E ratio
info
27.47
EBIDTA
info
$483M
Ex dividend date
info
-
Price & volume
Market cap
info
$8.73B
Average daily volume
info
0.2M
90-day return
info
-11.49%
30-day return
info
-18.94%
7-day return
info
-17.12%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
27.47
PEG ratio
info
1.19
Trailing P/E
info
0
Price to sales
info
3.38
Price to book
info
1.17
Earnings
EPS
info
-$28.08
EPS estimate (current quarter)
info
$1.16
EPS estimate (next quarter)
info
$2.76
EBITDA
info
$483M
Revenues (TTM)
info
$2.58B
Revenues per share (TTM)
info
$90.82
Technicals
Beta
info
0.94
52-week High
info
$387.99
52-week Low
info
$262.12
50-day moving average
info
$340.07
200-day moving average
info
$321.13
Short ratio
info
3.82
Short %
info
3.36%
Management effectiveness
ROE (TTM)
info
9.79%
ROA (TTM)
info
1.86%
Profit margin
info
30.18%
Gross profit margin
info
$1.41B
Operating margin
info
9.94%
Growth
Quarterly earnings growth (YoY)
info
541.20%
Quarterly revenue growth (YoY)
info
2.80%
Share stats
Outstanding Shares
info
22.9M
Float
info
19.4M
Insiders %
info
15.64%
Institutions %
info
85.05%
Analyst Insights & forecasts
info

67% Buy

33% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$401.17
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$3.10
$2.82
9.93%
Q4 • 23Beat
$2.29
$2.15
6.51%
Q1 • 24Beat
$3.11
$2.01
54.73%
Q2 • 24Beat
$2.01
$1.16
73.28%
Q3 • 24Beat
$2.90
$2.88
0.55%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$650M
$653M
100.53%
Q3 • 24
$668M
$-716M
107.24%
Q4 • 24
2.74%
209.59%
206.67%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$10.6B
$3.12B
29.38%
Q3 • 24
$9.36B
$2.79B
29.85%
Q4 • 24
11.69%
10.30%
1.58%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$97.6M
$-30.9M
$-96.6M
$55.4M
Q2 • 24
$164M
$-55.6M
$-96M
$100M
Q3 • 24
67.55%
79.89%
0.62%
80.57%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Bio-Rad Laboratories Inc share?
Collapse

Bio-Rad Laboratories Inc shares are currently traded for $277.16 per share.

How many shares does Bio-Rad Laboratories Inc have?
Collapse

Bio-Rad Laboratories Inc currently has 22.9M shares.

Does Bio-Rad Laboratories Inc pay dividends?
Collapse

No, Bio-Rad Laboratories Inc doesn't pay dividends.

What is Bio-Rad Laboratories Inc 52 week high?
Collapse

Bio-Rad Laboratories Inc 52 week high is $387.99.

What is Bio-Rad Laboratories Inc 52 week low?
Collapse

Bio-Rad Laboratories Inc 52 week low is $262.12.

What is the 200-day moving average of Bio-Rad Laboratories Inc?
Collapse

Bio-Rad Laboratories Inc 200-day moving average is $321.13.

Who is Bio-Rad Laboratories Inc CEO?
Collapse

The CEO of Bio-Rad Laboratories Inc is Norman D. Schwartz.

How many employees Bio-Rad Laboratories Inc has?
Collapse

Bio-Rad Laboratories Inc has 7,700 employees.

What is the market cap of Bio-Rad Laboratories Inc?
Collapse

The market cap of Bio-Rad Laboratories Inc is $8.73B.

What is the P/E of Bio-Rad Laboratories Inc?
Collapse

The current P/E of Bio-Rad Laboratories Inc is null.

What is the EPS of Bio-Rad Laboratories Inc?
Collapse

The EPS of Bio-Rad Laboratories Inc is -$28.08.

What is the PEG Ratio of Bio-Rad Laboratories Inc?
Collapse

The PEG Ration of Bio-Rad Laboratories Inc is 1.19.

What do analysts say about Bio-Rad Laboratories Inc?
Collapse

According to the analysts Bio-Rad Laboratories Inc is considered a buy.

Bio-Rad Laboratories Inc news